Doug Willson


Douglas “Doug” Willson, Ph.D., leads the forecasting and business strategy team in our Cambridge office. He has over 30 years of forecasting and quantitative market research experience within the life sciences industry.


Doug specializes in early-stage commercial assessments, pre-launch and in-line forecasts, and market sizing studies for pharmaceuticals, biotechnology, medical devices, and diagnostics. Doug also possesses a strong background in business strategy and promotional analytics.

Prior to Viscadia, Doug held a variety of  leadership roles at:

  • Ipsos Healthcare
  • ZS Associates
  • Bell Falla
  • Cello Health Advantage

Business Expertise

  • Demand Studies
  • Conjoint and Choice Modeling
  • Sales and Marketing Analytics
  • Product Development and New Product Planning

Therapeutic Expertise

  • Autoimmune
  • Cardiovascular/Diabetes
  • Oncology
  • Rare Diseases


  • Ph.D. in Economics (Econometrics, Finance)
    University of Pennsylvania
  • M.A. in Economics
    University of Toronto
  • B.Comm. in Finance
    University of Toronto